2 курс / Гистология / Марченко_Н_В_Клинико_морфологические_и_психоэмоциональные_взаимосвязи
.pdf211
Kanzler, S. Bozkurt, J. Herkel [et al.] // Dtsch. Med. Wochenschr. — 2001. — № 126.
— P. 450–456.
174.Kaplan, M. M. Primary biliary cirrhosis / M. M. Kaplan, M. E. Gershwin // N. Engl. J. Med. — 2005. — Vol. 353, № 12. — P. 1261–1273.
175.Karson, A. Chronic administration of infliximab (TNF-α inhibitor) decreases
depression and anxiety-like behaviour in rat model of chronic mild stress / A. Karson, T.
Demirtaş, D. Bayramgürler [et al.] // Basic Clin. Pharmacol. Toxicol. —2013. — Vol.
112, № 5. — P. 335-340
176.Kassiotis, G. Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level implications for pathogenesis and therapy of autoimmune demyelination / G. Kassiotis, G. Kollias // J. Exp. Med. — 2001. — № 193. — P. 427–434.
177.Kil, J. S. Long-term treatment outcomes for autoimmune hepatitis in Korea / J. S. Kil, J. H. Lee, A. R. Han [et al.] // J. Korean Med. Sci. — 2010. — Vol. 25, № 1. —
P. 54–60.
178. Kim, K. A. Clinical features and prognosis of primary biliary cirrhosis in Korea / K. A. Kim, S. H. Jeong, J. I. Lee [et al.] // Korean J. Hepatol. — 2010. — Vol. 16, №
2. — P. 139–146.
179. Kim, W. R. Epidemiology and natural history of primary biliary cirrhosis in a US community /W. R. Kim, K. D. Lindor, G. R. Locke 3rd [et al.] // Gastroenterol. — 2000. — Vol. 119, № 6. — P. 1631–1636.
180.Kita, H. Quantitative and functional analysis of PDC-E2–specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis / H. Kita, S. Matsumura, X. S. He [et al.] // J. Clin. Invest. — 2002. — Vol. 109, № 9. — P. 1231–1240.
181.Klöppel, G. Histopathological features in mixed types of chronic aggressive hepatitis and primary biliary cirrhosis. Correlations of liver histology with mitochondrial antibodies of different specificity / G. Klöppel, G. Seifert, H. Lindner [et al.] // Virchows Arch. Pathol. Anat. Histol. — 1977. — Vol. 373, № 2. — P. 143–160.
212
182.Knodell, R.G. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis / R.G. Knodell, K.G. Ishak, W.C. Black [et al.] // Hepatology. — 1981. — Vol.4. — P. 431-435.
183.Koga, H. Nuclear DNA fragmentation and expression of Bcl-2 in primary biliary cirrhosis / H. Koga, S. Sakisaka, M. Ohishi [et al.] // Hepatology. — 1997. —
Vol. 25, № 5. — P. 1077-1084.
184.Kremer, A. E. Pathophysiology and current management of pruritus in liver disease / A. E. Kremer, R. P. Oude Elferink, U. Beuers // Clin. Res. Hepatol. Gastroenterol. — 2011. — Vol. 35, № 2. — P. 89-97.
185.Kubo, S. Successful treatment of primary biliary cirrhosis with etanercept in a
patient with rheumatoid arthritis [Электронный |
ресурс] / S. |
Kubo, S. |
Iwata, K. |
Saito, Y. Tanaka // Joint. Bone Spine. |
— 2011. |
Режим |
доступа: |
http://www.sciencedirect.com/science/article/pii/S1297319X11001175 |
|
||
186.Kuiper, E. M. Paris criteria are effective in diagnosis of primary biliary cirrhosis and autoimmune hepatitis overlap syndrome / E. M. Kuiper, P. E. Zondervan, H. R. van Buuren // Clin. Gastroenterol. Hepatol. — 2010. — Vol. 8, № 6. — P. 530-534.
187.Kuiper, E. M. Relatively high risk for hepatocellular carcinoma in patients with primary biliary cirrhosis not responding to ursodeoxycholic acid / E. M. Kuiper, B. E. Hansen, R. P. Adang // Eur. J. Gastroenterol. Hepatol. — 2010. — Vol. 22, № 12. — P. 1495-1502.
188.Kumagi, T. Primary biliary cirrhosis [Электронный ресурс] / T. Kumagi, E. J.
Heathcote // Orphanet. J. Rare Dis. — 2008. Режим доступа:
http://www.ncbi.nlm.nih.gov/
189.Lähteenmäki, A. Quality of life before and after liver transplantation: experiences with 7 patients with primary biliary cirrhosis in a 2-year follow-up / A. Lähteenmäki, K. Höckerstedt, S. Kajaste, M. Huttunen // Transpl. Int. — 1992. —Vol. 5, Suppl 1. — P. S705-S707.
190.Lammert, C. Questionnaire based assessment of risk factors for primary biliary cirrhosis / C. Lammert, D. L. Nguyen, B. D. Juran [et al.] // Dig. Liver Dis. —2013. —
Vol. 45, № 7. — P. 589-594.
213
191.Lanquillon, S. Cytokine production and treatment response in major depressive disorder / S. Lanquillon, J. C. Krieg, U. Bening-Abu-Shach, H. Vedder // Neuropsychopharmacol. — 2000. — Vol. 22, № 4. — P. 370-379.
192.Laurin, J. M. The natural history of abdominal pain associated with primary biliary cirrhosis / J. M. Laurin, C. K. DeSotel, R. A. Jorgensen [et al.] // Am. J. Gastroenterol. — 1994. — Vol. 89, № 10. — P. 1840-1843.
193.Lefkowitch, J. H. Liver Biopsy Assessment in Chronic Hepatitis / J. H. Lefkowitch // Arch. Med. Res. — 2007. — Vol. 38, № 6. — P.10.
194.Levy, C. Management of osteoporosis, fat-soluble vitamin deficiencies, and
hyperlipidemia in primary biliary cirrhosis // C. Levy, K. D. Lindor // Clin. Liver
Dis. — 2003. — Vol. 7, № 4. — P. 901-910.
195.Li, M. Cytotoxic T-lymphocyte associated antigen-4 gene polymorphisms and primary biliary cirrhosis: a systematic review / M. Li, H. Zheng, T. Li, P. Gao // J. Gastroenterol. Hepatol. — 2012. — Vol. 27, № 7. — P. 1159-1166.
196.Licht, C. M. Association between major depressive disorder and heart rate variability in the Netherlands Study of Depression and Anxiety (NESDA) / C. M. Licht, E. J. de Geus, F. G. Zitman [et al.] // Arch. Gen. Psychiatry. — 2008. — Vol. 65, № 12.
— P. 1358-1367. |
|
|
|
197. |
Lindor, K. D. Primary biliary |
cirrhosis / |
K. D. Lindor, M. E. Gershwin, |
R. Poupon [et al.] // Hepatol. — 2009. — Vol. 50, № 1. — P. 291–308. |
|||
198. |
Lleo, A. Etiopathogenesis of |
primary |
biliary cirrhosis / A. Lleo, |
P. Invernizzi, I. R. Mackay // World J. Gastroenterol. — 2008. — Vol. 14, № 21. — P. 3328-3337.
199.Lleo, A. Apotopes and the biliary specificity of primary biliary cirrhosis / A. Lleo, C. Selmi, P. Invernizzi [et al.] //Hepatol. — 2009. — Vol. 49, № 3. — P. 871-879.
200.Loftis, J. M. Depressive symptoms in patients with chronic hepatitis C are correlated with elevated plasma levels of interleukin-1beta and tumor necrosis factoralpha / J. M. Loftis, M. Huckans, S. Ruimy [et al.] // Neurosci. Lett. — 2008. —
Vol. 430, № 3. — P. 264-268.
214
201.Lohse, A. W. Сharacterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: evidence for it being a hepatitic form of PBC in genetically susceptible individuals / A. W. Lohse, K. H. zum Buschenfelde, B. Franz [et al.] // Hepatol. — 1999. — Vol. 29, № 4. — P. 1078=1084.
202.Longhi, M. S. Aetiopathogenesis of autoimmune hepatitis / M. S. Longhi, Y. Ma, G. Mieli-Vergani, D. Vergani // J. Autoimmun. — 2010. — Vol. 34, № 1. — P. 7-
203.Longhi, M. S. Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis / M. S. Longhi, F. Meda, P. Wang // Hepatol. — 2008. — Vol. 47, № 2. — P. 581-591.
204.Lucena, M. I. Recurrent drug-induced liver injury (DILI) with different drugs in the Spanish Registry: the dilemma of the relationship to autoimmune hepatitis / M. I. Lucena, N. Kaplowitz, H. Hallal [et al.] // J. Hepatol. — 2011. — Vol. 55, № 4. —
P. 820-827.
205.Ludwig, J. Staging of chronic non-suppurative cholangitis (syndrome of primary biliary cirrhosis) / J. Ludwig, E. R. Dickson, G. S. McDonald // Virchows Arch. A Pathol. Anat. Histol. — 1978. — Vol. 379, № 2. — P. 103-112.
206.Ma, Y. Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease / Y. Ma, M. Okamoto, M. G. Thomas [et al.] // Hepatol. — 2002. — Vol. 35, № 3. — P. 658-664.
207.Ma, X. Cytokine gene polymorphisms in Chinese patients with type I autoimmune hepatitis / X. Ma, D. K. Qiu // Zhonghua Gan. Zang. Bing. Za. Zhi. —
2004. — № 12. — P. 296-298.
208.Mackay, I. R. Primary biliary cirrhosis showing a high titer of autoantibody; report of a case / I. R. Mackay // N. Engl. J. Med. — 1958. — Vol. 258, № 4. — P. 185-
209.Mackay, I. R. HLA associations with autoimmune-type chronic active hepatitis: identification of B8-DRw3 haplotype by family studies / I. R. Mackay, B. D. Tait // Gastroenterol. — 1980. — Vol. 79, № 1. — P. 95-98.
215
210. Mackay I. R. Autoimmune hepatitis / I. R. Mackay, S. Weiden, J. Hasker // Ann. N. Y. Acad. Sci. — 1965. — Vol. 124, № 2. — P. 767-780.
211. Maggiore, G. Circulating levels of interleukin-6, interleukin-8, and tumor necrosis factor-alpha in children with autoimmune hepatitis / G. Maggiore, F. De Benedetti, M. Massa [et al.] // J. Pediatr. Gastroenterol. Nutr. — 1995. — Vol. 20,
№ 1. — P. 23-27.
212.Mahmoudi, H. Validity and reliability of Persian version of Chronic Liver Disease Questionnaire (CLDQ) / H. Mahmoudi, P. Jafari, M. Alizadeh-Naini [et al.] // Qual. Life Res. — 2012. — Vol. 21, № 8. — P. 1479-1485.
213.Makol, A. Autoimmune hepatitis: a review of current diagnosis and treatment
[Электронный ресурс] / A. Makol, K. D. Watt // Hepat. Res. Treat. — 2011. Режим
доступа: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3132488/
214.Manns, M. P. Antibodies to soluble liver antigen: specific marker of autoimmune hepatitis / M. P. Manns // J. Hepatol. — 2000. — Vol. 33, № 2. — P. 326-
215.Manns, M. P. Diagnosis and management of autoimmune hepatitis / M. P. Manns, A. J. Czaja, J. D. Gorham [et al.] American Association for the Study of Liver Diseases // Hepatol. — 2010. — Vol. 51, № 6. — P. 2193-2213.
216.Manns, M. P. Autoimmune hepatitis, from mechanisms to therapy / M. P. Manns, A. Vogel // Hepatol. — 2006 — Vol. 43, № 2, Suppl. 1. — P. S132-S144.
217.Manosso, L. M. Antidepressant-like effect of α-tocopherol in a mouse model of depressive-like behavior induced by TNF-α / L. M. Manosso, V. B. Neis, M. Moretti [et al.] // Prog. Neuropsychopharmacol. Biol. Psychiatry. — 2013. — Vol. 46. — P. 48-57.
218.Mao, T. K. Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis / T. K. Mao, Z. X. Lian, C. Selmi [et al.] // Hepatol. — 2005.
— Vol. 42, № 4. — P. 802-808.
219.Mayo, M. J. Natural history of primary biliary cirrhosis / M. J. Mayo // Clin. Liver Dis. — 2008. — Vol. 12, № 2. — P. 277-288.
220.McElroy, S. L. Topiramate in the treatment of binge eating disorder associated
with obesity: a randomized, placebo-controlled trial / S. L. McElroy, L. M.
216
Arnold, N. A. Shapira [et al.] // Am. J. Psychiatry. — 2003. — Vol. 160, № 2. — P. 255-261.
221. Mela, M. Review article: pruritus in cholestatic and other liver diseases / M. Mela, A. Mancuso, A. K. Burroughs // Aliment. Pharmacol. Ther. — 2003. — Vol. 17,
№ 7. — P. 857-870.
222.Mells, G. The impact of primary biliary cirrhosis on perceived quality of life: The UK-PBC national study / G. Mells, G. Pells, J. L. Newton [et al.], UK-PBC Consortium // Hepatol. — 2013. — Vol. 58, № 1. — P. 273–283
223.Mieli-Vergani, G. Autoimmune hepatitis / G. Mieli-Vergani, D. Vergani // Nat. Rev. Gastroenterol. Hepatol. — 2011. — Vol. 8, № 6. — P. 320-329.
224.Mitchison, H. C. Positive antimitochondrial antibody but normal alkaline phosphatase: is this primary biliary cirrhosis? / H. C. Mitchison, M. F. Bassendine, A. Hendrick [et al.] // Hepatol. — 1986. — Vol. 6, № 6. — P. 1279-1284.
225.Miyake, Y. Clinical features of Japanese male patients with type 1 autoimmune hepatitis / Y. Miyake, Y. Iwasaki, K. Sakaguchi, Y. Shiratori // Aliment. Pharmacol. Ther. — 2006. — Vol. 24, № 3. — P. 519-523.
226.Mohan, A.K. Infectious complications of biologic treatments of rheumatoid arthritis / A. K. Mohan, T. R. Cote, J. N. Siegel, M. M. Braun // Curr. Opin. Rheumatol.
— 2003. — № 15. — P. 179-184.
227. Montano-Loza, A. J. Frequency, behavior, and prognostic implications of antimitochondrial antibodies in type 1 autoimmune hepatitis / A. J. Montano-Loza., H. A. Carpenter, A. J. Czaja // J. Clin. Gastroenterol. — 2008. — Vol. 42, № 9. —
P. 1047-1053.
228.Morgan, M. J. Reactive oxygen species in TNFalpha-induced signaling and cell death / M. J. Morgan, Z. G. Liu // Mol. Cells. — 2010. — Vol. 30, № 1. — P. 1-12.
229.Muratori, L. Antimitochondrial antibodies and other antibodies in primary biliary cirrhosis: diagnostic and prognostic value / L. Muratori, A. Granito, P. Muratori [et al.] / Clin. Liver Dis. — 2008. — Vol. 12, № 2. — P. 261-276.
217
230. Muratori, P. Validation of simplified diagnostic criteria for autoimmune hepatitis in Italian patients / P. Muratori, A. Granito, G. Pappas [et al.] // Hepatol. — 2009. — № 49. — P. 1782-1783.
231.Myers, R. P. Epidemiology and natural history of primary biliary cirrhosis in a
Canadian health region: a population-based study / R. P. Myers,
A. A. Shaheen, A. Fong [et al.] // Hepatol. — 2009. — Vol. 50, № 6. — P. 1884-1892. 232. Nagano, T. Cytokine profile in the liver of primary biliary cirrhosis / T. Nagano, K. Yamamoto, S. Matsumoto [et al.] // J. Clin. Immunol. — 1999. — Vol.
19, № 6. — P. 422-427.
233.Nakanuma, Y. Semiquantitative assessment of cholestasis and lymphocytic piecemeal necrosis in primary biliary cirrhosis: a histologic and immunohistochemical study / Y. Nakanuma, K. Saito, M. Unoura // J. Clin. Pathol. — 1990. — Vol. 12, № 3.
— P. 357–362.
234.Nakanuma, Y. Application of a new histological staging and grading system for primary biliary cirrhosis to liver biopsy specimens: Interobserver agreement. / Y. Nakanuma, Y. Zen, K. Harada [et al.] // Pathol. Int. — 2010. — Vol. 60, № 3. — P. 167–174.
235.Natoli, G. Tumor necrosis factor (TNF) receptor 1 signaling downstream of TNF receptor-associated factor 2. Nuclear factor kappaB (NFkappaB)-inducing kinase requirement for activation of activating protein 1 and NFkappaB but not of c-Jun N- terminal kinase/stress-activated protein kinase / G. Natoli, A. Costanzo, F. Moretti [et al.] // J. Biol. Chem. — 1997. — Vol. 272, № 42. — P. 26079-26082.
236.Neuhauser, M Autoimmune hepatitis-PBC overlap syndrome: a simplified
scoring system may assist in the diagnosis / M. Neuhauser, E. Bjornsson, S. Treeprasertsuk [et al.] // Am. J. Gastroenterol. — 2010. — Vol. 105, № 2. — P. 345353.
237.Neuman, M. Tumor necrosis factor-alpha and transforming growth factor-beta
reflect severity of liver damage in primary biliary cirrhosis / M. Neuman, P. Angulo, I. Malkiewicz [et al.] // J. Gastroenterol. Hepatol. — 2002. — Vol. 17, № 2. —
P. 196-202.
218
238. Neuman, M. G. Markers of inflammation and fibrosis in alcoholic hepatitis and viral hepatitis C [Электронный ресурс] / M. G. Neuman, H. Schmilovitz-Weiss, N. Hilzenrat [et al.] // Int. J. Hepatol. — 2012. Режим доступа: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3296182/
239. Nickel, R. The relevance of anxiety, depression, and coping in patients after liver transplantation / R. Nickel, A. Wunsch, U. Egle [et al.] // Liver Transpl. — 2002.
— Vol. 8, № 1. — P. 63–71.
240.Niro, G. A. TNF-alpha polymorphisms in primary biliary cirrhosis: a northern and southern Italian experience / G.A. Niro, F. Poli, A. Andriulli [et al.] // Ann. N. Y. Acad. Sci. — 2009. — № 1173. — P. 557-563.
241.Odin, J. A. Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis / J. A. Odin, R. C. Huebert, L. CasciolaRosen [et al.] // Clin. Invest. — 2001. — Vol. 108, № 2. — P. 223-232.
242.Oesterreicher, C. Centrilobular necrosis in autoimmune hepatitis: a histological feature associated with acute clinical presentation / C. Oesterreicher // J. Clin. Pathol. –
2006. — Vol. 59, № 3. — P. 246-249.
243.Okano, N. Clinicopathological features of acute-onset autoimmune hepatitis / N. Okano, K. Yamamoto, K. Sakaguchi [et al.] // Hepatol. Res. — 2003. — Vol. 25, № 3.
— P. 263–270.
244.O’Keeffe, C. Cholestatic pruritus - the role of cutaneous mast cells and nerves / C. O'Keeffe, A. W. Baird, N. Nolan, P. A. McCormick // Aliment. Pharmacol. Ther. —
2004. — Vol. 19, № 12. — P. 1293-300.
245. Olafsson, S. Antimitochondrial antibodies and reactivity to N. aromaticivorans proteins in Icelandic patients with primary biliary cirrhosis and their relatives / S. Olafsson, H. Gudjonsson, C. Selmi [et al.] // Am. J. Gastroenterol. — 2004. — Vol. 99,
№ 11. — P. 2143-2146.
246. O'Malley, W. E. Action of bacterial polysaccharide on tumors: II. Damage of Sarcoma 37 by serum of mice treated with Serratia marcescens polysaccharide, and induced tolerance / W. E. O'Malley, B. Achinstein, M. J. Shear // J. Natl. Cancer Inst. — 1962. — Vol. 29. — P. 1169-1175.
219
247.Onishi, S. DNA typing of HLA class II genes; DRB1*0803 increases the susceptibility of Japanese to primary biliary cirrhosis / S. Onishi, T. Sakamaki, T. Maeda // J. Hepatol. — 1994. — Vol. 21, № 6. — P. 1053-1060.
248.Oo, Y. H. Autoimmune hepatitis: new paradigms in the pathogenesis, diagnosis, and management / Y. H. Oo, S. G. Hubscher // Hepatol. Int. — 2010. — Vol. 4, № 2. —
P. 475-493.
249.Osawa, Y. Tumor necrosis factor-α promotes cholestasis-induced liver fibrosis in the mouse through tissue inhibitor of metalloproteinase-1 production in hepatic stellate cells / Y. Osawa, M. Hoshi, I. Yasuda [et al.] // PLoS One. — 2013. Режим доступа: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670853/
250.Padgett, K. A. Phylogenetic and immunological definition of four lipoylated proteins from Novosphingobium aromaticivorans, implications for primary biliary cirrhosis / K. A. Padgett, C. Selmi, T. P. Kenny [et al.] // J. Autoimmun. — 2005. —
Vol. 24, № 3. — P. 209-219.
251. Paiardini, A. Structural mimicry between SLA/LP and Rickettsia
surface antigens as a driver of autoimmune hepatitis: insights from an in silico study [Электронный ресурс] / A. Paiardini, S. Pascarella // Theor. Biol. Med. Model. — 2013. Режим доступа: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3636016/
252. Papadakis, K.A. Tumor necrosis factorbiology and therapeutic inhibitors /
K. A. Papadakis, S. R. Targan // Gastroenterol. — 2000. — № 119. — P. 1148-1157. 253. Pappo, O. Recurrent and de novo giant cell hepatitis after orthotopic liver transplantation / Pappo O., Yunis E., Jordan J.A. [et al.] // Am. J. Surg. Pathol. — 1994.
— Vol. 18, № 8. — P. 804-813.
254.Pares, A. Natural history of primary biliary cirrhosis / A. Pares, J. Rodes // Clin. Liver Dis. — 2003. — Vol. 7. — P. 779-794.
255.Parker, R. Management of patients with difficult autoimmune hepatitis / R. Parker, Y. H. Oo, D. H. Adams // Therap. Adv. Gastroenterol. — 2012. — Vol. 5, № 6.
— P. 421–437.
256.Pasparakis, M. Immune and inflammatory responses in TNF alpha-deficient micea critical requirement for TNF alpha in the formation of primary B cell follicles,
220
follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response / M. Pasparakis, L. Alexopoulou, V. Episkopou, G. Kollias // J. Exp. Med. — 1996. — №. 184. — P. 1397–1411.
257. Pennica, D. Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin / D. Pennica, G. E. Nedwin, J. S. Hayflick // Nature. — 1984. — Vol. 312, № 5996. — P. 724-729.
258. Perez-Alvarez, R. Biologics-induced autoimmune diseases / R. Perez-Alvarez, M. Pérez-de-Lis, M. Ramos-Casals // Curr. Opin. Rheumatol. — 2013. — Vol. 25, № 1.
— P. 56-64.
259.Pérez-San-Gregorio, M. Á. Quality of life and mental health comparisons among liver transplant recipients and cirrhotic patients with different self-perceptions of health / M. Á. Pérez-San-Gregorio, A. Martín-Rodríguez, E. Domínguez-Cabello [et al.] // J. Clin. Psychol. Med. Settings. — 2013. — Vol. 20, № 1. — P. 97-106.
260.Pfeffer, K. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection / K. Pfeffer, T. Matsuyama, T.M. Kundig [et al.] // Cell. — 1993. — Vol. 7, № 73. — P. 457–467.
261.Popper, H. Nonsuppurative destructive chronic cholangitis and chronic hepatitis / H. Popper, F. Schaffner // Prog. Liver. Dis. — 1970. — № 3. — 336–354.
262.Poupon, R. Primary biliary cirrhosis: A 2010 update / R. Poupon // J. Hepatol.
— 2010. — Vol. 52, Issue 5. — P. 745–758.
263. Poupon, R. E. Clinical and biochemical expression of the histopathological lesions of primary biliary cirrhosis. UDCA-PBC Group / R. Е. Poupon, O. Chazouilleres, B. Balkau, R. E. Poupon // J. Hepatol. — 1999. — Vol. 30. — P. 408– 412.
264. Poupon, R. E. Quality of life in patients with primary biliary cirrhosis / R. E. Poupon, Y. Chretien, O. Chazouilleres [et al.] // Hepatol. — 2004. — Vol. 40, № 2. —
P. 489–494.
265. Pratt, D. S. A novel histological lesion in glucocorticoid-responsive chronic hepatitis / D. S. Pratt, K. A. Fawaz, A. Rabson [et al.] // Gastroenterol. — 1997. — Vol.
113, № 1. — P. 664-668.